Medicine access in Portugal: reliable rules and practical limits
Portugal receives 79 out of 100 points for medicine access. A regulated pharmacy market, public reimbursement and the national medicines authority create dependable structures, although shortages and the transfer of foreign prescriptions still require planning.
INFARMED plays a central role in authorisation, safety monitoring, pricing and reimbursement. Prescription medicines are dispensed through pharmacies, while the amount paid by a patient depends on the medicine, reimbursement category and personal entitlement.
The transition is often the hardest stage for a newcomer. A medicine may have a different brand name, pack size or prescription status in Portugal. The international generic name, strength and formulation are more useful than familiar packaging.
Good access does not mean that every product is stocked in every pharmacy. Shortages, rare medicines, controlled drugs and hospital-only therapies follow different pathways. Complex treatment should be coordinated with a clinician, pharmacy and insurer before a move.
What the access index covers
The index combines availability, regulatory stability, pharmacy access, reimbursement structures and the practical continuation of common treatments. It matches the visible rating and is not repeated as a second points figure.
Portugal’s strong position is consistent with an EU-regulated market, a nationwide pharmacy network and established public financing. It does not promise that a particular brand is available or fully reimbursed.
INFARMED publishes data on authorisation, market supply, use and reimbursement. This provides an institutional evidence base beyond individual traveller reports.
Prescriptions, reimbursement and equivalent products
Portuguese clinicians prescribe under national and European rules. Generic alternatives exist for many common active ingredients. Substitution can reduce cost, but medicines with a narrow therapeutic range or a specific formulation require clinical caution.
Reimbursement depends on more than the product. Diagnosis, prescription, registration and entitlement can all matter. A private prescription may be valid without receiving the same public subsidy as a prescription issued through the eligible public pathway.
Electronic prescriptions make dispensing within Portugal easier. Some prescriptions from other EU countries can be recognised, but controlled substances, special products and incomplete documents are more difficult. Local clinical care is more dependable for a long-term resident.
During a shortage, a pharmacy may check another strength, package or equivalent active ingredient. Dose or formulation should not be changed without appropriate clinical advice.
Continuing long-term treatment without a gap
Before moving, prepare a concise record of generic name, strength, formulation, dose and clinical indication. A medical summary in English or Portuguese is especially useful for psychiatric medicines, anticoagulants, hormones and rare-disease treatment.
A lawful transition supply can protect against delays but does not replace import checks. Controlled medicines may require certificates or quantity limits, and the relevant authorities should be consulted before travel.
Treatment requiring refrigeration, infusion or hospital dispensing needs more than a local pharmacy. A specialist clinic, supply route, payment approval and storage plan should all be confirmed.
Pharmacy coverage and specialist supply
Cities have dense pharmacy coverage, and standard items that are not in stock can often be ordered. Opening hours and out-of-hours duty vary, so urgent access should be checked locally.
Rural areas and islands may have less immediate choice. This is more relevant to rare products and rapid special orders than to ordinary primary-care medicines.
Specialised and high-cost drugs may be supplied through hospital pharmacies or defined programmes. Access then depends on specialist supervision and documented clinical indication.
What to check before making a decision
- Record generic names rather than brand names alone.
- Check Portuguese availability and prescription status before moving.
- Confirm reimbursement entitlement and possible co-payments.
- Review import rules for controlled medicines.
- Confirm the specialist clinic and supply route for complex treatment.
What this indicator does not measure
The indicator does not price every medicine or guarantee stock at a particular pharmacy. It cannot determine whether a medicine is clinically suitable for an individual.
Short-term supply disruption can change faster than a national assessment. Life-sustaining treatment requires a direct availability check.
How to read the rating
The strong rating reflects a regulated and generally accessible medicines market. Co-payments, shortages and additional controls on rare or restricted products account for the remaining limitations.
Portugal is straightforward for many standard therapies. The more specialised the treatment, the more important local prescribing, specialist care and advance payment approval become.
Frequently Asked Questions
Can a foreign prescription be filled in Portugal?
Some prescriptions from EU countries can be recognised when all required details are present. Controlled and specialised medicines are subject to stricter rules.
Are medicines free under the public system?
Not generally. Reimbursement varies by medicine, indication and entitlement, and a co-payment may remain.
What if a familiar brand is unavailable?
A pharmacist can search for the same active ingredient and strength. Clinically sensitive substitutions should be confirmed by a doctor.
Can a personal supply be brought into Portugal?
A reasonable personal supply may be possible, but quantity, documentation and controlled-drug rules must be checked before travel.
Related indicators
Sources
- INFARMED: medicine authorisation, safety and reimbursement
- INFARMED medicine and healthcare products statistics
- Portuguese Health Regulatory Authority: rights of access to care
This article was created on July 11, 2026
